Close Menu

Proteomics software provider BioAnalyte has adopted a licensing strategy that it considers unique in the bioinformatics industry, which allows the firm “to sell into a disposables budget rather than a capital software budget,” according to Peter Leopold, president of BioAnalyte.

The company’s software, called Trawler, is a data-reduction tool for cleaning mass spec peak lists. In line with Trawler — and the company’s nautical product theme — is the so-called Nets license, which is available for $100 and tied to an individual chromatogram.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.

Sponsored by

This webinar will discuss the implementation of an enterprise-wide clinical genomics platform that is shared across 10 hospitals and research organizations in the Australian State of Victoria.